XOMA Royalty Corporation (NASDAQ: XOMA) related to its sale to Ligand Pharmaceuticals Incorporated. Under the terms of the proposed transaction, XOMA shareholders will receive $39.00 per share in cash.
XOMA Royalty Corporation (NASDAQ: XOMA) related to its sale to Ligand Pharmaceuticals Incorporated. Under the terms of the proposed transaction, XOMA shareholders will receive $39.00 per share in cash.